Pasche Named Cancer Center Director | Leading the Way in Regenerative Medicine | Innovation Quarter Welcomes Forsyth Tech’s Center for Emerging Technologies | Wake Forest Innovations Partners with Korean CHA Health Systems | Partnership with Appalachian State to Address PA Shortage in Underserved Areas | Joint Venture with Gentiva Health Services to Focus on Post-hospital Care | Appointments | Full News Articles
Pasche Named Cancer Center Director
Pasche, a native of Switzerland, is also the principal investigator of the Cancer Center’s National Cancer Institute core grant, continuing its strong tradition of research excellence while expanding basic, clinical and translational research in collaboration with departmental and center leadership.
He previously served as director of the division of hematology/oncology at the University of Alabama at Birmingham. His internationally recognized research has included identifying the first mutation of a gene that controls cell growth and discovering that some individuals carry an altered form of the gene, which increases their risk of developing several forms of cancer. He has also identified one of the first genetic links between obesity and breast and colon cancer.
Pasche holds medical degrees from the University of Lausanne in Switzerland, and the Karolinska Institute in Stockholm, Sweden, where he also received his PhD. He completed a postdoctoral research fellowship at Brigham and Women’s Hospital, Harvard Medical School; his residency in internal medicine at New York Hospital, Weill Cornell Medical Center; and a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center and New York Hospital, Weill Cornell Medical College.
© 2014 Wake Forest Baptist Medical Center | Office of Development and Alumni Affairs | P.O. Box 571021 | Winston-Salem, NC 27157-1021 | All Rights Reserved.